Medgend Icon

Ledgend of Medicine







discontinued


Trexall

Behcet's syndrome is a disease that involves vasculitis, which is inflammation of the blood vessels. It causes problems in many parts of the body. The most common symptoms are:

  • Sores in the mouth
  • Sores on the sex organs
  • Other skin sores
  • Swelling of parts of the eye
  • Pain, swelling and stiffness of the joints

More serious problems can include meningitis, blood clots, inflammation of the digestive system and blindness.

Doctors aren't sure what causes Behcet's. It is rare in the United States, but is common in the Middle East and Asia. It mainly affects people in their 20s and 30s. Diagnosing Behcet's can take a long time, because symptoms may come and go, and it may take months or even years to have all of the symptoms. There is no cure. Treatment focuses on reducing pain and preventing serious problems. Most people can control symptoms with treatment.

NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases

Trexall FDA Approved Drugs

METHOTREXATE PRESERVATIVE FREE [Methotrexate SodiumC20H20N8O52Na]
RX
-
eq 1gm base/vial (injection injectable)
eq 25mg base/ml (injection injectable)
Fresenius Kabi UsaFeb 26, 1999
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

METHOTREXATE SODIUM [Methotrexate SodiumC20H20N8O52Na]
RX
-
eq 100mg base/4ml (eq 25mg base/ml) (injection injectable)
eq 2.5mg base (oral tablet)
eq 200mg base/8ml (eq 25mg base/ml) (injection injectable)
eq 250mg base/10ml (eq 25mg base/ml) (injection injectable)
eq 50mg base/2ml (eq 25mg base/ml) (injection injectable)
West-ward Pharms IntSep 16, 1986
BarrOct 15, 1990
Dava Pharms IncApproved Prior To Jan 1, 1982
Hq Spclt PharmaMay 21, 2015
MylanMay 15, 1992
Zydus Pharms Usa IncJan 13, 2017
Fresenius Kabi UsaFeb 26, 1999
HospiraDec 15, 2004
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

METHOTREXATE SODIUM PRESERVATIVE FREE [Methotrexate SodiumC20H20N8O52Na]
RX
-
eq 100mg base/4ml (eq 25mg base/ml) (injection injectable)
eq 1gm base/40ml (eq 25mg base/ml) (injection injectable)
eq 1gm base/vial (injection injectable)
eq 200mg base/8ml (eq 25mg base/ml) (injection injectable)
eq 250mg base/10ml (eq 25mg base/ml) (injection injectable)
eq 50mg base/2ml (eq 25mg base/ml) (injection injectable)
Mylan Labs LtdMar 29, 2012
Pharmachemie BvFeb 27, 2012
Accord HlthcareApr 30, 2007
HospiraApr 13, 2005
Sandoz IncMar 31, 2009
West-ward Pharms IntAug 12, 2005
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TREXALL [Methotrexate SodiumC20H20N8O52Na]
RX
-
eq 10mg base (oral tablet)
eq 15mg base (oral tablet)
eq 5mg base (oral tablet)
eq 7.5mg base (oral tablet)
BarrMar 21, 2001
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

XATMEP [Methotrexate SodiumC20H20N8O52Na]
RX
-
eq 2.5mg base/ml (oral solution)
Silvergate PharmsApr 25, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.